As of 2024-12-14, the EV/EBITDA ratio of Repligen Corp (RGEN) is -122.21. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. RGEN's latest enterprise value is 8,501.29 mil USD. RGEN's TTM EBITDA according to its financial statements is -69.56 mil USD. Dividing these 2 quantities gives us the above RGEN EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 18.7x - 20.5x | 20.2x |
| Forward P/E multiples | 20.3x - 23.9x | 22.0x |
| Fair Price | (18.51) - 55.37 | 15.41 |
| Upside | -111.8% - -64.6% | -90.1% |
| Date | EV/EBITDA |
| 2024-12-13 | -122.21 |
| 2024-12-12 | -121.87 |
| 2024-12-11 | -121.27 |
| 2024-12-10 | -118.61 |
| 2024-12-09 | -120.85 |
| 2024-12-06 | -116.40 |
| 2024-12-05 | -110.81 |
| 2024-12-04 | -116.31 |
| 2024-12-03 | -115.84 |
| 2024-12-02 | -117.42 |
| 2024-11-29 | -117.48 |
| 2024-11-27 | -117.04 |
| 2024-11-26 | -114.42 |
| 2024-11-25 | -113.87 |
| 2024-11-22 | -111.07 |
| 2024-11-21 | -110.41 |
| 2024-11-20 | -108.10 |
| 2024-11-19 | -99.72 |
| 2024-11-18 | -95.63 |
| 2024-11-15 | -96.69 |
| 2024-11-14 | -110.95 |
| 2024-11-13 | -117.42 |
| 2024-11-12 | -115.91 |
| 2024-11-11 | -108.60 |
| 2024-11-08 | -109.55 |
| 2024-11-07 | -112.12 |
| 2024-11-06 | -113.77 |
| 2024-11-05 | -113.78 |
| 2024-11-04 | -108.61 |
| 2024-11-01 | -107.87 |
| 2024-10-31 | -104.38 |
| 2024-10-30 | -106.08 |
| 2024-10-29 | -104.86 |
| 2024-10-28 | -106.74 |
| 2024-10-25 | -105.33 |
| 2024-10-24 | -105.11 |
| 2024-10-23 | -106.96 |
| 2024-10-22 | -112.33 |
| 2024-10-21 | -116.41 |
| 2024-10-18 | -114.59 |
| 2024-10-17 | -110.71 |
| 2024-10-16 | -107.52 |
| 2024-10-15 | -113.00 |
| 2024-10-14 | -111.45 |
| 2024-10-11 | -108.04 |
| 2024-10-10 | -104.55 |
| 2024-10-09 | -106.21 |
| 2024-10-08 | -104.98 |
| 2024-10-07 | -106.24 |
| 2024-10-04 | -106.34 |